IP Library Granted Patent US 10,632,166
Granted Patent B2
US 10,632,166 · App. 14/766,497 · Granted Apr 28, 2020

Bioactive compositions from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,166
App. No.
14/766,497
Granted
Apr 28, 2020
Kind
B2
Abstract

The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant. The bioactive compositions are suitable for use in, inter alia, beverages, functional foods, nutriceuticals, supplements, and the like.

Claims (87)

1. A beverage comprising at least one bioactive composition dispersed in a liquid, %

wherein said liquid is selected from the group consisting of water, shot drink, functional drink, green tea, oolong tea, black tea, white tea, flavored tea, soft drink, coffee, milk, shake, alcoholic drink, non-alcoholic drink, sports drink, fruit juice, vegetable juice, artificially sweetened juice, sparkling water, punch, cider and nutritional supplement drink;

wherein said bioactive composition comprising a bioactive fraction derived from a Theacea plant;

wherein said bioactive fraction derived from a Theaceae plant is selected from the group consisting of a membrane fraction, a membrane fraction extract, a cytoplasm fraction, a cytoplasm fraction extract, a cell juice serum, and combinations thereof, for use as an antioxidant

wherein Oxygen Radical Absorbance Capacity (ORAC) value of said bioactive composition is over twenty times higher than a green tea beverage that does not contain said bioactive composition; and,

wherein said bioactive fraction comprises at least 1150 μg/ml of L-Theanine.

2. The beverage according to claim 1 , wherein said Theaceae plant is a Camellia plant or a Eurya plant.

3. The beverage according to claim 2 , wherein said Camellia plant is selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua , and wherein said Eurya plant is Eurya sandwicensis.

4. The beverage according to claim 1 , wherein said bioactive fraction is a membrane fraction.

5. The beverage according to claim 1 , wherein said bioactive fraction is membrane fraction extract.

6. The beverage according to claim 5 , wherein said membrane fraction extract has a total catechin content of between about 15.0 and about 30.5 milligrams per gram of dry matter.

7. The beverage according to claim 5 , wherein said membrane fraction extract has a catechin content profile comprising:

between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,

between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,

between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,

between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,

between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane, and

between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.

8. The beverage composition according to claim 1 , wherein said bioactive fraction is a cytoplasm fraction.

9. The beverage composition according to claim 1 , wherein said bioactive fraction is a cytoplasm fraction extract.

10. The beverage according to claim 1 , wherein said bioactive fraction is a cell juice serum.

11. The beverage according to claim 10 , wherein said cell juice serum has a total catechin content of between about 8.0 and about 20.0 milligrams per gram of dry matter.

12. The beverage according to claim 10 , wherein said cell juice serum has a catechin content profile comprising:

between about 2.1 and about 4.4 milligrams of (−)-epigallocatechin per gram of dry matter of the cell juice serum,

between about 4.2 and about 8.6 milligrams of (+)-catechin per gram of dry matter of the cell juice serum,

between about 0.2 and about 2.0 milligrams of (−)-epicatechin per gram of dry matter of the cell juice serum,

between about 1.2 and about 3.2 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the cell juice serum,

between about 0.01 and about 0.1 milligrams of (−)-gallocatechin gallate per gram of dry matter of the cell juice serum, and

between about 0.2 and about 1.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the cell juice serum.

13. The beverage according to claim 1 further comprising a stabilizing agent.

14. The beverage according to claim 13 , wherein said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.

15. A nutriceutical product for use by a human subject as an antioxidant comprising at least one bioactive composition derived from Theaceae plant, said bioactive composition comprising an isolated bioactive fraction derived from a Theaceae plant selected from the group consisting of a membrane fraction, a membrane fraction extract, a cytoplasm fraction, a cytoplasm fraction extract, a cell juice serum, and combinations thereof,

wherein said Theacea plant is a Camellia plant selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua ; or a Eurya plant, which is Eurya sandwicensis ; and,

wherein said bioactive fraction comprises at least 1150 μg/ml of L-Theanine, and,

wherein said bioactive fraction has antioxidant activity when administered to the human subject orally as the nutriceutical product, and,

wherein Oxygen Radical Absorbance Capacity (ORAC) value of said bioactive composition is over twenty times higher than a second nutriceutical product that does not contain said bioactive composition.

16. The nutriceutical product according to claim 15 , wherein said Theaceae plant is a Camellia plant or a Eurya plant.

17. The nutriceutical product according to claim 16 , wherein said Camellia plant is selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua , and wherein said Eurya plant is Eurya sandwicensis.

18. The nutriceutical product according to claim 15 , wherein said membrane fraction extract has a total catechin content of between about 15.0 and about 30.5 milligrams per gram of dry matter.

19. The nutriceutical product according to claim 15 , wherein said membrane fraction extract has a catechin content profile comprising:

between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,

between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,

between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,

between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,

between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane fraction extract, and

between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.

20. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cytoplasm fraction.

21. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cytoplasm fraction extract.

22. The nutriceutical product according to claim 15 , wherein said bioactive fraction is a cell juice serum.

23. The nutriceutical product according to claim 22 , wherein said cell juice serum has a total catechin content of between about 8.0 and about 20.0 milligrams per gram of dry matter.

24. The nutriceutical product according to claim 22 , wherein said cell juice serum has a catechin content profile comprising:

between about 2.1 and about 4.4 milligrams of (−)-epigallocatechin per gram of dry matter of the cell juice serum,

between about 4.2 and about 8.6 milligrams of (+)-catechin per gram of dry matter of the cell juice serum,

between about 0.2 and about 2.0 milligrams of (−)-epicatechin per gram of dry matter of the cell juice serum,

between about 1.2 and about 3.2 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the cell juice serum,

between about 0.01 and about 0.1 milligrams of (−)-gallocatechin gallate per gram of dry matter of the cell juice serum, and

between about 0.2 and about 1.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the cell juice serum.

25. The nutriceutical product according to claim 15 further comprising a stabilizing agent.

26. The nutriceutical product according to claim 25 , wherein said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.

27. A functional food product for use by a human subject as an antioxidant, said functional food product comprising at least one bioactive composition comprising an isolated bioactive fraction derived from a Theaceae plant selected from the group consisting of a membrane fraction, a membrane fraction extract, a cytoplasm fraction, a cytoplasm fraction extract, a cell juice serum, and combinations thereof,

wherein said bioactive fraction has antioxidant activity when administered to the human subject orally as the functional food product, and,

wherein said bioactive fraction comprises at least 1150 μg/ml of L-Theanine, and,

wherein Oxygen Radical Absorbance Capacity (ORAC) value of said bioactive composition is over twenty times higher than a second functional food product that does not contain said bioactive composition, and

wherein said Theacea plant is a Camellia plant selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua ; or a Eurya plant, which is Eurya sandwicensis.

28. The functional food product according to claim 27 , wherein said Theaceae plant is a Camellia plant or a Eurya plant.

29. The functional food product according to claim 28 , wherein said Camellia plant is selected from the group consisting of Camellia sinensis, Camellia japonica, Camellia reticulate , and Camellia sasanqua , and wherein said Eurya plant is Eurya sandwicensis.

30. The functional food product according to claim 27 , wherein said membrane fraction extract has a total catechin content of between about 15.0 and about 30.5 milligrams per gram of dry matter.

31. The functional food product according to claim 27 , wherein said membrane fraction extract has a catechin content profile comprising:

between about 1.7 and about 3.3 milligrams of (−)-epigallocatechin per gram of dry matter of the membrane fraction extract,

between about 6.1 and about 10.2 milligrams of (+)-catechin per gram of dry matter of the membrane fraction extract,

between about 0.3 and about 1.1 milligrams of (−)-epicatechin per gram of dry matter of the membrane fraction extract,

between about 6.2 and about 12.5 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the membrane fraction extract,

between about 0.007 and about 0.03 milligrams of (−)-gallocatechin gallate per gram of dry matter of the membrane fraction extract, and

between about 1.3 and about 3.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the membrane fraction extract.

32. The functional food product according to claim 27 , wherein said bioactive fraction is a cytoplasm fraction.

33. The functional food product according to claim 27 , wherein said bioactive fraction is a cytoplasm fraction extract.

34. The functional food product according to claim 27 , wherein said bioactive fraction is a cell juice serum.

35. The functional food product according to claim 34 , wherein said cell juice serum has a total catechin content of between about 8.0 and about 20.0 milligrams per gram of dry matter.

36. The functional food product according to claim 35 , wherein said cell juice serum has a catechin content profile comprising:

between about 2.1 and about 4.4 milligrams of (−)-epigallocatechin per gram of dry matter of the cell juice serum,

between about 4.2 and about 8.6 milligrams of (+)-catechin per gram of dry matter of the cell juice serum,

between about 0.2 and about 2.0 milligrams of (−)-epicatechin per gram of dry matter of the cell juice serum,

between about 1.2 and about 3.2 milligrams of (−)-epigallocatechin gallate per gram of dry matter of the cell juice serum,

between about 0.01 and about 0.1 milligrams of (−)-gallocatechin gallate per gram of dry matter of the cell juice serum, and

between about 0.2 and about 1.3 milligrams of (−)-epicatechin gallate per gram of dry matter of the cell juice serum.

37. The functional food product according to claim 27 further comprising a stabilizing agent.

38. The functional food product according to claim 37 , wherein said stabilizing agent is selected from the group consisting of an emulsifier, a preservative, an antioxidant, a polymer matrix, and mixtures thereof.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded Mar 1, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041844/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: AKZO NOBEL SURFACE CHEMISTRY LLC; AKZO NOBEL CHEMICALS INTERNATIONA B.V.
To: ISP INVESTMENTS INC.
Reel/Frame 036583/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2015
From: KOGANOV, MICHAEL; DUEVA-KOGANOV, OLGA V.; DUEV, ARTYOM; HOU, XIAOWEN
To: AKZO NOBEL CHEMICALS INTERNATIONAL B.V.
Reel/Frame 036306/0591 →